Beijing Double-crane Pharmaceutical Acquires Shenzhou Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
Guangdong Shenzhou Pharmaceutical, one of the few companies producing soft packaging for transfusion in South China, faces huge debts after establishing four advanced production lines for PVC soft packaging. Beijing Double-crane Pharmaceutical will acquire 90 percent stake of the cash-strapped company for a token 1 yuan; the purchase will double its soft packaging production capacity and improve current processes and bottom line. The acquisition of high-tech hardware and manufacturing facilities will strengthen Double-crane's position in South China and improve its nationwide production network. Double-crane will incorporate Shenzhou's management, production, purchase and allocation processes into its management model for maximum optimization. (Click here for more - Chinese Language)